Fatherhood during dabrafenib and trametinib therapy for metastatic melanoma

被引：9

作者：

Cocorocchio, Emilia ^{[1
]}

Pala, Laura ^{[1
]}

Battaglia, Angelo ^{[1
]}

Gandini, Sara ^{[2
]}

Peccatori, Fedro Alessandro ^{[3
]}

Ferrucci, Pier Francesco ^{[1
]}

机构：

[1] Ist Europeo Oncol, Melanoma Unit, Via Giuseppe Ripamonti 435, I-20141 Milan, Italy

[2] Ist Europeo Oncol, Div Biostat, Milan, Italy

[3] Ist Europeo Oncol, Fertil Unit, Milan, Italy

来源：

ACTA ONCOLOGICA | 2018年 / 57卷 / 08期

关键词：

SPERMATOGENESIS; IMATINIB; BRAF;

D O I：

10.1080/0284186X.2018.1449251

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1131 / 1133

页数：3

共 12 条

[1] Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial [J].

Amaria, Rodabe N. ;

Prieto, Peter A. ;

Tetzlaff, Michael T. ;

Reuben, Alexandre ;

Andrews, Miles C. ;

Ross, Merrick J. ;

Glitza, Isabella C. ;

Cormier, Janice ;

Hwu, Wen-Jen ;

Tawbi, Hussein A. ;

Patel, Sapna P. ;

Lee, Jeffrey E. ;

Gersbenwaid, Jeffrey E. ;

Spencer, Christine N. ;

Gopalakrishnan, Vancheswaran ;

Bassett, Roland ;

Simpson, Lauren ;

Mouton, Rosalind ;

Hudgens, Courtney W. ;

Zhao, Li ;

Zhu, Haifeng ;

Cooper, Zachary A. ;

Wani, Khalida ;

Lazar, Alexander ;

Hwu, Patrick ;

Diab, Adi ;

Wong, Michael K. ;

McQuade, Jennifer L. ;

Royal, Richard ;

Lucci, Anthony ;

Burton, Elizabeth M. ;

Reddy, Sangeetha ;

Sharma, Padmanee ;

Allison, James ;

Futreal, Phillip A. ;

Woodman, Scott E. ;

Davies, Michael A. ;

Wargo, Jennifer A. .

LANCET ONCOLOGY, 2018, 19 (02) :181-193

[2]

[Anonymous], GENECARDS HUM GEN DA

[3]

Cohen C, 2002, CLIN CANCER RES, V8, P3728

[4] Distinct sets of genetic alterations in melanoma [J].

Curtin, JA ;

Fridlyand, J ;

Kageshita, T ;

Patel, HN ;

Busam, KJ ;

Kutzner, H ;

Cho, KH ;

Aiba, S ;

Bröcker, EB ;

LeBoit, PE ;

Pinkel, D ;

Bastian, BC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20) :2135-2147

[5] International trends in the incidence of malignant melanoma 1953-2008uare recent generations at higher or lower risk? [J].

Erdmann, Friederike ;

Lortet-Tieulent, Joannie ;

Schuez, Joachim ;

Zeeb, Hajo ;

Greinert, Ruediger ;

Breitbart, Eckhard W. ;

Bray, Freddie .

INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (02) :385-400

[6] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma [J].

Flaherty, Keith T. ;

Robert, Caroline ;

Hersey, Peter ;

Nathan, Paul ;

Garbe, Claus ;

Milhem, Mohammed ;

Demidov, Lev V. ;

Hassel, Jessica C. ;

Rutkowski, Piotr ;

Mohr, Peter ;

Dummer, Reinhard ;

Trefzer, Uwe ;

Larkin, James M. G. ;

Utikal, Jochen ;

Dreno, Brigitte ;

Nyakas, Marta ;

Middleton, Mark R. ;

Becker, Juergen C. ;

Casey, Michelle ;

Sherman, Laurie J. ;

Wu, Frank S. ;

Ouellet, Daniele ;

Martin, Anne-Marie ;

Patel, Kiran ;

Schadendorf, Dirk .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) :107-114

[7] Treatment of Metastatic Malignant Melanoma With Vemurafenib During Pregnancy [J].

Maleka, Aglaia ;

Enblad, Gunilla ;

Sjors, Gunnar ;

Lindqvist, Anna ;

Ullenhag, Gustav J. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (11) :E192-E193

[8] Effects of chemotherapy and radiotherapy on spermatogenesis in humans [J].

Meistrich, Marvin L. .

FERTILITY AND STERILITY, 2013, 100 (05) :1180-1186

[9] Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model [J].

Schultheis, Beate ;

Nijmeijer, Bart A. ;

Yin, H. ;

Gosden, Roger G. ;

Melo, Junia V. .

LEUKEMIA RESEARCH, 2012, 36 (03) :271-274

[10] Fatherhood during imatinib [J].

Shash, Emad ;

Bassi, Simona ;

Cocorocchio, Emilia ;

Colpi, Giovanni Maria ;

Cinieri, Saverio ;

Peccatori, Fedro Alessandro .

ACTA ONCOLOGICA, 2011, 50 (05) :734-735

← 1 2 →